Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mycobacterial disease prevention: pharmacovigilance and inflammatory disease
Site and Loop Directed Mutagenesis Studies of 2FE-2 Ferredoxins
Molecular and Functional Analysis of CASK in Epithelia
Bone Morphogenetic Proteins in Arterial Remodeling
Statistical Aspects of Cvd Clinical Trials
Recently added grants:
Characterization of EPHA3 intragenic rearrangements in high-grade serous carcinoma progression and recurrence
Early Phase Clinical Research Support
A Personalized Digital Outreach Intervention for Lung Cancer Screening
Program 1: Breast Cancer
Program 3: Prostate Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52206-10-0-1
Application #
7568307
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/ Mayo Clinic, Rochester
$201,306
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Ames, Matthew /
$184,964
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/
NIH 2007
N01 CA
/
NIH 2007
N01 CA
/
NIH 2007
N01 CA
/
NIH 2007
N01 CA
/
Comments
Be the first to comment on this grant